摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-(羟甲基)-1-苯基环己烷-1-醇 | 24927-50-2

中文名称
2-(羟甲基)-1-苯基环己烷-1-醇
中文别名
——
英文名称
2-Hydroxymethyl-1-phenyl-cyclohexanol
英文别名
1-Phenyl-2-(hydroxymethyl)cyclohexan-1-ol;1-Phenyl-2-hydroxymethylen-1-cyclohexanol;2-Hydroxymethyl-1-phenylcyclohexanol;2-(Hydroxymethyl)-1-phenylcyclohexan-1-ol
2-(羟甲基)-1-苯基环己烷-1-醇化学式
CAS
24927-50-2
化学式
C13H18O2
mdl
——
分子量
206.285
InChiKey
AEPWPCRJAHECSU-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.5
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.54
  • 拓扑面积:
    40.5
  • 氢给体数:
    2
  • 氢受体数:
    2

SDS

SDS:0c210c1072ea5dd76566d9346fc79f84
查看

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    参考文献:
    名称:
    摘要:
    Purpose. To design and evaluate a new class of soft anticholinergics with subtype selectivity.Methods. A new class of soft anticholinergics was designed based on the "inactive metabolite" approach. Four compounds were synthesized. The potency and soft nature of the compounds were evaluated by receptor binding, cardiac, and mydriatic studies. Stability and pharmacokinetic studies were also performed on these newly synthesized soft anticholinergics.Results. Receptor binding studies of the soft anticholinergics on cloned muscarinic receptors indicated pKi values in the range of 7.5 to 8.9. Two compounds, 9a and 13a, of the series showed muscarinic subtype receptor selectivity (M-3/M-2). In mydriatic studies, 13a and 13b showed shorter duration of action in the treated eyes than tropicamide. In the control eyes, significant dilation of pupils was found only in rabbits treated with atropine and tropicamide, indicating that the soft anticholinergics lack systemic effects because of their facile hydrolytic deactivation. Consistent with their soft nature, this new class of soft anticholinergics displayed much shorter cardiovascular effects in the carbachol-induced bradycardia (10 to 15 min) in rats than atropine (>60 min). Stability and pharmacokinetic studies suggested that the new soft anticholinergics were rapidly eliminated from plasma (systemic circulation) after i.v. administration.Conclusions. A new class of anticholinergics was designed and synthesized, and the PK/PD evaluation confirmed they were potent "soft" anticholinergics; two of them showed muscarinic receptor subtype selectivity (M-3/M-2).
    DOI:
    10.1023/a:1026160023030
  • 作为产物:
    参考文献:
    名称:
    摘要:
    Purpose. To design and evaluate a new class of soft anticholinergics with subtype selectivity.Methods. A new class of soft anticholinergics was designed based on the "inactive metabolite" approach. Four compounds were synthesized. The potency and soft nature of the compounds were evaluated by receptor binding, cardiac, and mydriatic studies. Stability and pharmacokinetic studies were also performed on these newly synthesized soft anticholinergics.Results. Receptor binding studies of the soft anticholinergics on cloned muscarinic receptors indicated pKi values in the range of 7.5 to 8.9. Two compounds, 9a and 13a, of the series showed muscarinic subtype receptor selectivity (M-3/M-2). In mydriatic studies, 13a and 13b showed shorter duration of action in the treated eyes than tropicamide. In the control eyes, significant dilation of pupils was found only in rabbits treated with atropine and tropicamide, indicating that the soft anticholinergics lack systemic effects because of their facile hydrolytic deactivation. Consistent with their soft nature, this new class of soft anticholinergics displayed much shorter cardiovascular effects in the carbachol-induced bradycardia (10 to 15 min) in rats than atropine (>60 min). Stability and pharmacokinetic studies suggested that the new soft anticholinergics were rapidly eliminated from plasma (systemic circulation) after i.v. administration.Conclusions. A new class of anticholinergics was designed and synthesized, and the PK/PD evaluation confirmed they were potent "soft" anticholinergics; two of them showed muscarinic receptor subtype selectivity (M-3/M-2).
    DOI:
    10.1023/a:1026160023030
点击查看最新优质反应信息

文献信息

  • ADVANCED POLY EPOXY ESTER RESIN COMPOSITIONS
    申请人:Jin Xin
    公开号:US20130178591A1
    公开(公告)日:2013-07-11
    A poly epoxy ester resin composition of the following chemical structure: where n is a number from 2 to about 3000; each m independently has a value of 0 or 1; each R 0 is independently —H or —CH 3 ; each R 1 is independently —H or a C 1 to C 6 alkylene radical (saturated divalent aliphatic hydrocarbon radical), Ar is a divalent aryl group or heteroarylene group;_and X is cycloalkylene group, including substituted cycloalkylene group, where the substitute group include an alkyl, cycloalkyl, an aryl or an aralkyl group or other substitute group, for example, a halogen, a nitro, a blocked isocyanate, or an alkyloxy group; the combination of cycloalkylene and alkylene groups and the combination of alkylene and cycloalkylene group with a bridging moiety in between.
    以下是化学结构式为的聚合物环氧酯树脂组成:其中n为2至约3000的数字;每个m独立地具有值为0或1;每个R0独立地为—H或—CH3;每个R1独立地为—H或C1到C6的烷基基团(饱和二价脂肪族碳氢基团),Ar为二价芳基基团或杂芳基基团;X为环烷基团,包括取代环烷基团,其中取代基团包括烷基、环烷基、芳基或芳基烷基团或其他取代基团,例如卤素、硝基、阻塞异氰酸酯或烷氧基团;环烷基和烷基团的组合以及烷基和环烷基团之间带有桥接基团。
  • HYBRID EPOXY RESINS
    申请人:DOW GLOBAL TECHNOLOGIES LLC
    公开号:US20140114047A1
    公开(公告)日:2014-04-24
    A hybrid polyfunctional aliphatic and/or cycloaliphatic epoxy (H-PACE) resin composition comprising, consisting of or consisting essentially of: (a) a moiety selected from the group consisting of an aliphatic moiety, a cycloaliphatic moiety, and combinations thereof provided by the polyfunctional aliphatic and/or cycloaliphatic epoxy (PACE) resin; and (b) a moiety selected from the group consisting of an aliphatic moiety, a cycloaliphatic moiety, and combinations thereof, wherein said moiety is not provided by the PACE resin, is disclosed. Processes for making and using such resin composition are also disclosed.
    本发明涉及一种混合多功能脂肪族和/或环脂族环氧(H-PACE)树脂组合物,包括、由以下成分组成或实质上由以下成分组成:(a)由多功能脂肪族和/或环脂族环氧(PACE)树脂提供的脂肪族、环脂族或两者的一部分;以及(b)由不由PACE树脂提供的脂肪族、环脂族或两者的一部分。本发明还公开了制备和使用这种树脂组合物的方法。
  • The Cleavage Reaction of 1,3-Diols. III. The Synthesis of a Pair of Diastereomeric Ditertiary 1,3-Diols and an Effect of Configuration on Mode of Cleavage<sup>1</sup>
    作者:Howard E. Zimmerman、James English
    DOI:10.1021/ja01638a003
    日期:1954.5
  • PROCESS FOR PREPARING EPOXY RESINS
    申请人:Dow Global Technologies LLC
    公开号:EP2621991A1
    公开(公告)日:2013-08-07
  • EPOXY RESIN ADDUCTS AND THERMOSETS THEREOF
    申请人:Dow Global Technologies LLC
    公开号:EP2621992A2
    公开(公告)日:2013-08-07
查看更多